Hooman Bakhshi, MD
Interventional Cardiology · Baltimore, MDNPI 1396088878
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (57.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 65.9% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $21,592 and has fallen 85.5% since, to $3,127 in 2025.
Across 177 payments — averaging $182.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$21K
- Abbott$4K
- Boston Scientific$3K
- Edwards Lifesciences$2K
- Philips North America LLC$751
- Shockwave Medical, Inc$333
- plus $1K from 12 others
What the payments were for
- Grants$18,50057%
- Travel & lodging$6,42620%
- Food & beverage$7,43023%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 46 | $21,338 |
| Abbott | 40 | $3,768 |
| Boston Scientific | 17 | $3,040 |
| Edwards Lifesciences | 18 | $1,816 |
| Philips North America LLC | 5 | $751 |
| Shockwave Medical, Inc | 19 | $333 |
| Cardiovascular Systems Inc. | 2 | $245 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $217 |
| Abiomed | 2 | $159 |
| Asahi Intecc USA, Inc. | 1 | $111 |
| Kestra Medical Technology Services, Inc. | 2 | $108 |
| Stryker | 2 | $104 |
| E.r. Squibb & Sons, L.L.C. | 4 | $90 |
| Boehringer Ingelheim | 3 | $76 |
| Amgen | 2 | $74 |
| Merck | 3 | $64 |
| Cook Medical LLC | 1 | $49 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL VASCULAR ACCESS$1,722
- COREVALVE EVOLUT R$1,689
- XIENCE SKYPOINT$1,420
- Edwards SAPIEN 3 Transcatheter Heart Valve$747
- VersaCross Access Solution$671
- (9525) Intracardiac Und$657
- OPTIS$272
- DRAGONFLY OPSTAR$248
- Diamondback Coronary$245
- SAPIEN 3 Ultra RESILIA$233
- CardioMEMS HF System$160
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$150
- MitraClip$148
- MitraClip System$146
- Impella$136
- Telescope$128
- AVEIR$126
- OPTICROSS$125
- ASAHI PTCA Guide Wire$111
- Optis Coronary Imaging System$104
How this compares
$32,357 in reported general payments places this provider in the 80th percentile of 71 interventional cardiology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Baltimore
- Aloke FinnBaltimore$575K
- John WangBaltimore$138K
- Diljon ChahalBaltimore$78K
- Jon ResarBaltimore$40K
- Faisal RahmanBaltimore$36K
- Matthew VossBaltimore$33K
- Daniel AmbinderBaltimore$32K
- Rani HasanBaltimore$22K
- Ajar KocharBaltimore$22K
- Hani AlkhatibBaltimore$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.